Weight Loss

GLP-1 -agents single agonist Semaglutide (Ozempic) used for treatment of type 2 diabetes and anti-obesity and to reduce cardiovascular events and reduce the risk of chronic kidney disease.

GIP-GLP- Dual receptor agonist Tirzepatide (Mounjaro)approved for weight managment with obesity and weight related conditions. decreases nausea and increases white adipose fat loss.

GLP-1, GIP,and Glucagon - A triple receptor agononist. Retaturtide  a partial GLP-1 agonist, full GIP agonist and partial GCG agonist. Brown adipose thermogenisis, cardio protective and weight loss with muscle preserving abilities along with insulin resistant and metabolic health.